IONS logo

Ionis Pharmaceuticals Inc (IONS)

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the trea...

NASDAQHealthcareBiotechnologyUSA

Company Profile

Stock Code
IONS
ISIN Code
US4622221004
Currency
US Dollar (USD)
IPO Date
1991-05-17

Contact Information

Company Address
2855 Gazelle Court, Carlsbad, CA, United States, 92010
Contact Phone
760 931 9200
Company Website
https://www.ionis.com
Fiscal Year End
December

Financial Highlights

Market Capitalization
$999,999.99
Gross Profit (TTM)
$-999,999.99
Return on Assets (TTM)
-12.43%
EBITDA
$-999,999.99
Revenue (TTM)
$999,999.99